Oropouche virus: A neglected global arboviral threat
- PMID: 38224842
- PMCID: PMC10827532
- DOI: 10.1016/j.virusres.2024.199318
Oropouche virus: A neglected global arboviral threat
Abstract
The Oropouche virus is an important arthropod-borne virus in the Peribunyaviridae family that can cause febrile illnesses, and it is widely distributed in tropical regions such as Central and South America. Since the virus was first identified, a large number of related cases are reported every year. No deaths have been reported to date, however, the virus can cause systemic infections, including the nervous and blood systems, leading to serious complications. The transmission of Oropouche virus occurs through both urban and sylvatic cycles, with the anthropophilic biting midge Culicoides paraensis serving as the primary vector in urban areas. Direct human-to-human transmission of Oropouche virus has not been observed. Oropouche virus consists of three segments, and the proteins encoded by the different segments enables the virus to replicate efficiently in the host and to resist the host's immune response. Phylogenetic analyses showed that Oropouche virus sequences are geographically distinct and have closer homologies with Iquitos virus and Perdoes virus, which belong to the family Peribunyaviridae. Despite the enormous threat it poses to public health, there are currently no licensed vaccines or specific antiviral treatments for the disease it causes. Recent studies have utilised imJatobal virusmunoinformatics approaches to develop epitope-based peptide vaccines, which have laid the groundwork for the clinical use of vaccines. The present review focuses on the structure, epidemiology, immunity and phylogeny of Oropouche virus, as well as the progress of vaccine development, thereby attracting wider attention and research, particularly with regard to potential vaccine programs.
Keywords: Epidemiology; Evolutionary; Immunity; Oropouche virus; Structure; Vaccine development.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Evolutionary Dynamics of Oropouche Virus in South America.J Virol. 2020 Feb 14;94(5):e01127-19. doi: 10.1128/JVI.01127-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31801869 Free PMC article.
-
Oropouche fever, an emergent disease from the Americas.Microbes Infect. 2018 Mar;20(3):135-146. doi: 10.1016/j.micinf.2017.11.013. Epub 2017 Dec 14. Microbes Infect. 2018. PMID: 29247710 Review.
-
Epidemiology, transmission dynamics, treatment strategies, and future perspectives on Oropouche virus.Diagn Microbiol Infect Dis. 2025 Sep;113(1):116882. doi: 10.1016/j.diagmicrobio.2025.116882. Epub 2025 May 1. Diagn Microbiol Infect Dis. 2025. PMID: 40367910 Review.
-
Oropouche virus: Understanding "sloth fever" disease dynamics and novel intervention strategies against this emerging neglected tropical disease.Virulence. 2024 Dec;15(1):2439521. doi: 10.1080/21505594.2024.2439521. Epub 2024 Dec 13. Virulence. 2024. PMID: 39670816 Free PMC article.
-
Oropouche Fever: A Review.Viruses. 2018 Apr 4;10(4):175. doi: 10.3390/v10040175. Viruses. 2018. PMID: 29617280 Free PMC article. Review.
Cited by
-
The emergence of oropouche fever: A potential new threat?New Microbes New Infect. 2025 May 10;65:101596. doi: 10.1016/j.nmni.2025.101596. eCollection 2025 Jun. New Microbes New Infect. 2025. PMID: 40491501 Free PMC article.
-
Epigallocatechin-3-gallate: a multi-target bioactive molecule derived from green tea against Oropouche virus-a computational approach to host-pathogen network modulation.Front Chem. 2025 Jul 3;13:1590498. doi: 10.3389/fchem.2025.1590498. eCollection 2025. Front Chem. 2025. PMID: 40678119 Free PMC article.
-
The underdiagnosed threat of oropouche fever amidst dengue epidemics in Brazil.Lancet Reg Health Am. 2024 Mar 19;32:100718. doi: 10.1016/j.lana.2024.100718. eCollection 2024 Apr. Lancet Reg Health Am. 2024. PMID: 38545033 Free PMC article. No abstract available.
-
Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems.Trop Dis Travel Med Vaccines. 2025 Jan 2;11(1):1. doi: 10.1186/s40794-024-00236-x. Trop Dis Travel Med Vaccines. 2025. PMID: 39748388 Free PMC article. Review.
-
The Oropouche virus (OROV) and need of advanced diagnostics to mitigate it.Ann Med Surg (Lond). 2025 Mar 27;87(4):2516-2517. doi: 10.1097/MS9.0000000000003131. eCollection 2025 Apr. Ann Med Surg (Lond). 2025. PMID: 40212184 Free PMC article. No abstract available.
References
-
- Acrani G.O., Tilston-Lunel N.L., Spiegel M., Weidmann M., Dilcher M., Andrade da Silva D.E., Nunes M.R.T., Elliott R.M. Establishment of a minigenome system for Oropouche virus reveals the S genome segment to be significantly longer than reported previously. J. Gen. Virol. 2015;96:513–523. doi: 10.1099/jgv.0.000005. - DOI - PubMed
-
- Aguilar P.V., Barrett A.D., Saeed M.F., Watts D.M., Russell K., Guevara C., Ampuero J.S., Suarez L., Cespedes M., Montgomery J.M., Halsey E.S., Kochel T.J. Iquitos virus: a novel reassortant orthobunyavirus associated with human illness in Peru. PLoS Negl. Trop. Dis. 2011;5:e1315. doi: 10.1371/journal.pntd.0001315. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical